Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Allo Uridine
2. Allo-uridine
3. Allouridine
1. 58-96-8
2. Uridin
3. Uracil Riboside
4. 1-beta-d-ribofuranosyluracil
5. Uracil, 1-beta-d-ribofuranosyl-
6. Beta-uridine
7. D-uridine
8. B-uridine
9. Nsc 20256
10. 1-.beta.-d-ribofuranosyluracil
11. Chebi:16704
12. Urd
13. Ai3-52690
14. 1-((2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1h,3h)-dione
15. Whi7hq7h85
16. Mls000069625
17. Nsc-20256
18. Smr000058222
19. Mfcd00006526
20. 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
21. 1-beta-d-ribofuranosylpyrimidine-2,4(1h,3h)-dione
22. 1-beta-d-ribofuranosylpyrimidine-2,4(1h,3h)-dione (uridine)
23. 1-((2r,3r,4s,5r)-tetrahydro-3,4-dihydroxy-5-(hydroxymethyl)furan-2-yl)pyrimidine-2,4(1h,3h)-dione
24. 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
25. 3083-77-0
26. Einecs 200-407-5
27. Unii-whi7hq7h85
28. Arau
29. Nsc20256
30. D-ribosyl Uracil
31. .beta.-uridine
32. Uridine,(s)
33. 1af2
34. 4jx9
35. 4pd6
36. Opera_id_118
37. Uridine [inci]
38. Uridine, >=99%
39. Uridine [mi]
40. Uridine [mart.]
41. 1-b-d-ribofuranosyluracil
42. Uridine [usp-rs]
43. Uridine [who-dd]
44. 1-a-d-ribofuranosyluracil
45. Bmse000158
46. Bmse000816
47. Bmse000864
48. Epitope Id:149164
49. 1-.beta.-d-ribofuranosyl-2,4(1h,3h)-pyrimidinedione
50. Beta-d-ribofuranosyl-uridine
51. Schembl20667
52. Uracil-1-a-d-ribofuranoside
53. Rg2417
54. Uridine, Bioultra, >=99%
55. Uridine [usp Impurity]
56. Chembl100259
57. Gtpl4566
58. 1-beta-delta-ribofuranosyluracil
59. Dtxsid40891555
60. Uracil-1-.beta.-d-ribofuranoside
61. Hms2230p13
62. Hms3884m20
63. Hy-b1449
64. Zinc2583633
65. Bdbm50088517
66. S2029
67. Akos015896922
68. Am83934
69. Ccg-214447
70. Cs-5153
71. Db02745
72. Smp1_000029
73. Ncgc00017312-02
74. Ncgc00017312-04
75. Ncgc00017312-05
76. Ncgc00142368-01
77. 1-[(4s,2r,3r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-dihydropyrimi Dine-2,4-dione
78. Ds-14345
79. Sri-10895_12
80. Uridine, Vetec(tm) Reagent Grade, 99%
81. Adenosine Impurity F [ep Impurity]
82. Db-030519
83. U0020
84. C00299
85. 1-b-d-ribofuranosyl-2,4(1h,3h)-pyrimidinedione
86. B-d-ribofuranoside 2,4(1h,3h)-pyrimidinedione-1
87. Q422573
88. Brd-k13050303-001-18-1
89. Uridine, Powder, Bioreagent, Suitable For Cell Culture
90. .beta.-d-ribofuranoside, 2,4(1h,3h)-pyrimidinedione-1
91. 1-beta-delta-ribofuranosyl-2,4(1h,3h)-pyrimidinedione
92. 6b6fa3f8-70a2-44ea-b99c-d35d0a9237aa
93. Beta-delta-ribofuranoside 2,4(1h,3h)-pyrimidinedione-1
94. 1-.beta.-d-ribofuranosylpyrimidine-2,4(1h,3h)-dione
95. 1-beta-d-ribofuranosyluracil, Uracil-1-beta-d-ribofuranoside
96. Uridine, United States Pharmacopeia (usp) Reference Standard
97. 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione
98. Uridine, Pharmagrade, Manufactured Under Appropriate Controls For Use As A Raw Material In Pharma Or Biopharmaceutical Production
| Molecular Weight | 244.20 g/mol |
|---|---|
| Molecular Formula | C9H12N2O6 |
| XLogP3 | -2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 2 |
| Exact Mass | 244.06953611 g/mol |
| Monoisotopic Mass | 244.06953611 g/mol |
| Topological Polar Surface Area | 119 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 371 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in bipolar disorders and manic disorders.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
USP
ANALYTICAL
ABOUT THIS PAGE
A Uridine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Uridine, including repackagers and relabelers. The FDA regulates Uridine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Uridine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Uridine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Uridine supplier is an individual or a company that provides Uridine active pharmaceutical ingredient (API) or Uridine finished formulations upon request. The Uridine suppliers may include Uridine API manufacturers, exporters, distributors and traders.
click here to find a list of Uridine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Uridine DMF (Drug Master File) is a document detailing the whole manufacturing process of Uridine active pharmaceutical ingredient (API) in detail. Different forms of Uridine DMFs exist exist since differing nations have different regulations, such as Uridine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Uridine DMF submitted to regulatory agencies in the US is known as a USDMF. Uridine USDMF includes data on Uridine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Uridine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Uridine suppliers with USDMF on PharmaCompass.
Uridine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Uridine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Uridine GMP manufacturer or Uridine GMP API supplier for your needs.
A Uridine CoA (Certificate of Analysis) is a formal document that attests to Uridine's compliance with Uridine specifications and serves as a tool for batch-level quality control.
Uridine CoA mostly includes findings from lab analyses of a specific batch. For each Uridine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Uridine may be tested according to a variety of international standards, such as European Pharmacopoeia (Uridine EP), Uridine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Uridine USP).
LOOKING FOR A SUPPLIER?
